Kilitch Drugs (India) bulk deals, insider trading and stake changes
NSE: KILITCHBSE: 524500Pharmaceuticals & BiotechnologySmall Cap
Last close ₹202.24up ₹0.13 (0.06%)BSE ₹203.50
Share price at the NSE close on 23 Oct 2026. Previous close ₹202.11.
52-week range of traded prices to 23 Oct 2026
₹117.25Low, 30 Mar 2026₹267.90High, 7 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹707 Cr1,776th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 23.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 15 May 2026
- 2.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 12.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 8.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 15 May 2026
- 0.32
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,44,52347.0% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Kilitch Drugs (India) promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Others: no market trade · 1 pledge filing of unclear kind
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Kilitch Drugs (India) insider trading
All 21 disclosures on record. The company's own latest disclosure on record is from Aug 2024.Insider trading, all companies
Jun 2026
- DIPEN JAYANTILAL JAIN₹0.19 Cr10,520 sharesPledge · Designated Person · 17 Jun 2026 · disclosed 22 Jun
Mar 2026
- BonusEach share became 2 on 24 Mar 2026. The lines below are on the share count before it.
Aug 2025
- MUKUND PRATAPRAI MEHTA₹0.49 Cr14,000 sharesBought · Promoter And Designated Person · 28 Aug 2025 · disclosed 3 Sep
Aug 2024
- Bhavin Mehta8,41,046sharesGave · Promoter Group · 23 Aug 2024 · disclosed 27 Aug · Inter-se-Transfer · stake 20.92% before, 15.69% after
- Mira Mehta8,41,046sharesReceived · Director · 23 Aug 2024 · disclosed 27 Aug · Inter-se-Transfer · holds 8,41,046 after, stake 5.23% after
Sep 2023
- MUKUND MEHTA₹4.80 Cr2,50,000 sharesBought · Promoter And Designated Person · 5 Sep 2023 · disclosed 11 Sep
- BHAVIN MEHTA₹4.80 Cr2,50,000 sharesBought · Promoter And Designated Person · 5 Sep 2023 · disclosed 11 Sep
Apr 2022
- Mukund Mehta11,11,768sharesGave · Promoters · 22 Apr 2022 · Inter-se-Transfer · stake 12.85% before, 5.72% after
- Bhavin Mehta11,11,768sharesReceived · Promoters · 22 Apr 2022 · Inter-se-Transfer · stake 12.85% before, 19.99% after
- Mukund Mehta11,11,768sharesReceived · Promoters · 11 Apr 2022 · Others · stake 5.72% before, 12.86% after
Earlier, Apr 2016 to Oct 2020Hide earlier
Oct 2020
- Bhavin Mehta₹1.02 Cr1,03,300 sharesReleased · Promoters · 22 Oct 2020 · disclosed 28 Oct · Revokation of Pledge · stake 12.92% before, 12.92% after
Sep 2020
- Bhavin Mehta₹0.96 Cr1,03,300 sharesPledged · Promoters · 18 Sep 2020 · disclosed 28 Oct · Pledge Creation · stake 12.94% before, 12.94% after
Jun 2019
- Bhavin Mehta8,49,116sharesReceived · Promoters · 27 Jun 2019 · disclosed 29 Jun · Inter-se-Transfer · stake 7.48% before, 12.99% after
- Mukund Mehta8,49,116sharesGave · Promoters · 27 Jun 2019 · disclosed 29 Jun · Inter-se-Transfer · stake 11.28% before, 5.78% after
Aug 2018
- Bhavin Mehta₹0.80 Cr8,00,000 sharesReceived · Promoters · 31 Aug 2018 · disclosed 4 Sep · Conversion of security · held 3,53,300 before, holds 11,53,300 after
- Neeta Mehta₹0.63 Cr6,27,000 sharesReceived · Promoters · 31 Aug 2018 · disclosed 4 Sep · Conversion of security · held 4,84,768 before, holds 11,11,768 after
- Mukund Mehta₹0.17 Cr1,73,000 sharesReceived · Promoters · 31 Aug 2018 · disclosed 4 Sep · Conversion of security · held 15,66,763 before, holds 17,39,763 after
Mar 2018
- Mukund Mehta₹0.06 Cr60,000 sharesReceived · Promoters · 29 Mar 2018 · disclosed 30 Apr · Conversion of security · held 15,06,763 before, holds 15,66,763 after
- Neeta Mehta₹0.19 Cr1,90,000 sharesReceived · Promoters · 29 Mar 2018 · disclosed 30 Apr · Conversion of security · held 2,94,768 before, holds 4,84,768 after
- Bhavin Mehta₹0.25 Cr2,50,000 sharesReceived · Promoters · 29 Mar 2018 · disclosed 30 Apr · Conversion of security · held 1,03,300 before, holds 3,53,300 after
Apr 2016
- Paresh Mehta9,56,785sharesGave · Promoters · 13 Apr 2016 · Inter-se-Transfer · held 9,56,785 before
- Mukund Mehta9,56,785sharesReceived · Promoters · 13 Apr 2016 · disclosed 14 Apr · Inter-se-Transfer · held 5,49,978 before, holds 15,06,763 after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Kilitch Drugs (India) stake sales and purchases
All 14 disclosures on record.
Mar 2026
- BonusEach share became 2 on 24 Mar 2026. The lines below are on the share count before it.
Apr 2022
- AcquiredMukund Mehta · promoter7.13% of the company11,11,768 sharesholds 7.13% after11 Apr 2022 · filed under the 5% rule · Off-market
Jun 2019
- SoldBhavin Mehta · promoter5.51% of the company8,49,116 sharesholds 5.78% after27 Jun 2019 · filed under the 2% rule · Inter-se transfer
- AcquiredBhavin Mehta · promoter5.51% of the company8,49,116 sharesholds 12.99% after27 Jun 2019 · filed under the 2% rule · Inter-se transfer
Aug 2018
- AcquiredMukund Mehta · promoter1.13% of the company1,73,000 sharesholds 11.33% after31 Aug 2018 · filed under the 2% rule
- AcquiredBhavin Mehta · promoter5.21% of the company8,00,000 sharesholds 7.51% after31 Aug 2018 · filed under the 2% rule
- AcquiredNeeta Mehta · promoter4.08% of the company6,27,000 sharesholds 7.25% after31 Aug 2018 · filed under the 2% rule
Mar 2018
- AcquiredBhavin Mehta · promoterholds 80,000 shares after29 Mar 2018 · filed under the 2% rule
- AcquiredBhavin Mehta · promoter1.82% of the company2,50,000 sharesholds 2.57% after29 Mar 2018 · filed under the 2% rule
- AcquiredMukund Mehta · promoterholds 1,73,000 shares after29 Mar 2018 · filed under the 2% rule
- AcquiredMukund Mehta · promoter0.44% of the company60,000 sharesholds 11.40% after29 Mar 2018 · filed under the 2% rule
- AcquiredNeeta Mehta · promoterholds 6,27,000 shares after29 Mar 2018 · filed under the 2% rule
- AcquiredNeeta Mehta · promoter1.38% of the company1,90,000 sharesholds 3.53% after29 Mar 2018 · filed under the 2% rule
Apr 2016
- AcquiredMukund P Mehta · promoter7.23% of the company9,56,785 sharesholds 11.39% after13 Apr 2016 · filed under the 2% rule · Inter-se transfer
- SoldParesh P Mehta · promoter7.23% of the company9,56,785 sharesholds none after13 Apr 2016 · filed under the 2% rule · Inter-se transfer
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Kilitch Drugs (India) bulk deals
Last 12 months, since 23 Oct 2025: 2 bulk deals, ₹1.30 Cr bought and ₹4.77 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
BonusEach share became 2 on 24 Mar 2026. The lines below are on the share count before it.
Tuesday 28 Oct 20251 firm · ₹1.30 Cr bought · ₹4.77 Cr soldNet sold ₹3.47 Cr
- Both waysSHRENI SHARES PVTBought 32,332 at ₹401.82Sold 1,17,495 at ₹405.580.67% of the companyNet −85,163 shares₹1.30 Cr bought
Tuesday 6 Mar 20182 firms · ₹0.75 Cr bought · ₹1.20 Cr soldNet sold ₹0.45 Cr
- SoldSHAH DIPAK KANAYALALSold 66,699 at ₹96.350.50% of the company₹0.64 Cr
- Both waysBP FINTRADE PRIVATE LIMITEDBought 78,214 at ₹96.36Sold 56,811 at ₹98.980.59% of the companyNet +21,403 shares₹0.75 Cr bought
Thursday 1 Mar 20181 firm · ₹0 bought · ₹0.93 Cr soldNet sold ₹0.93 Cr
- SoldSHAH DIPAK KANAYALALSold 80,000 at ₹115.880.60% of the company₹0.93 Cr
Tuesday 27 Feb 20181 firm · ₹0.89 Cr bought · ₹0.95 Cr soldNet sold ₹0.06 Cr
- Both waysRONAK BANSALBought 72,184 at ₹122.90Sold 72,184 at ₹131.280.55% of the companyNet nil₹0.89 Cr bought
Monday 22 Jan 20183 firms · ₹3.91 Cr bought · ₹3.91 Cr soldNet nil
- Both waysARUNA DINESH SHAHBought 1,50,400 at ₹89.32Sold 1,50,400 at ₹85.231.14% of the companyNet nil₹1.34 Cr bought
- Both waysSUDHIR MOHANLAL JOSHIBought 1,50,410 at ₹85.40Sold 1,50,410 at ₹89.321.14% of the companyNet nil₹1.28 Cr bought
- Both waysANKUR TUKARAM MAYEKARBought 1,50,200 at ₹85.23Sold 1,50,200 at ₹85.391.14% of the companyNet nil₹1.28 Cr bought
Friday 23 Oct 20151 firm · ₹0.18 Cr bought · ₹0.37 Cr soldNet sold ₹0.19 Cr
- Both waysCHETAN RAJNIKANT PAREKHBought 35,000 at ₹50.82Sold 74,000 at ₹50.230.56% of the companyNet −39,000 shares₹0.18 Cr bought
Tuesday 20 Oct 20151 firm · ₹0.33 Cr bought · ₹0.32 Cr soldNet bought ₹0.01 Cr
- Both waysAJAY DESAI (HUF)Bought 74,261 at ₹44.41Sold 72,496 at ₹44.070.56% of the companyNet +1,765 shares₹0.33 Cr bought
Wednesday 7 Jan 20151 firm · ₹0.35 Cr bought · ₹0.64 Cr soldNet sold ₹0.29 Cr
- Both waysVERMA ARUNBought 63,996 at ₹54.59Sold 1,19,285 at ₹53.960.90% of the companyNet −55,289 shares₹0.35 Cr bought
Monday 5 Jan 20151 firm · ₹0.42 Cr bought · ₹0.23 Cr soldNet bought ₹0.19 Cr
- Both waysVERMA ARUNBought 86,261 at ₹49.07Sold 46,758 at ₹50.100.65% of the companyNet +39,503 shares₹0.42 Cr bought
Friday 21 Sep 20123 firms · ₹4.87 Cr bought · ₹4.87 Cr soldNet nil
- BoughtKILITCH COMPANY PHARMA LIMITEDBought 6,16,600 at ₹78.954.66% of the company₹4.87 Cr
- SoldMUKUND MEHTASold 3,08,300 at ₹78.952.33% of the company₹2.43 Cr
- SoldPARESH PRATAPRAI MEHTASold 3,08,300 at ₹78.952.33% of the company₹2.43 Cr
Wednesday 15 Sep 20101 firm · ₹1.00 Cr bought · ₹0 soldNet bought ₹1.00 Cr
- BoughtSHAREKHAN LTD A/C Diversified EquityBought 75,000 at ₹132.970.57% of the company₹1.00 Cr
Tuesday 22 Dec 20091 firm · ₹0 bought · ₹1.35 Cr soldNet sold ₹1.35 Cr
- SoldSHARON BIO MEDICINE LTDSold 1,00,000 at ₹135.470.76% of the company₹1.35 Cr
Thursday 26 Apr 20071 firm · ₹0 bought · ₹0.26 Cr soldNet sold ₹0.26 Cr
- SoldRUBAIYAT ARUN PATELSold 58,457 at ₹44.00₹0.26 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 28 deals on record from 4 Jan 2004.